BRIEF published on 06/26/2025 at 10:36, 1 year ago CHEPLAPHARM's €750M Bond Sees High Demand and Attractive Pricing Pharmaceuticals Investor Confidence Financial Flexibility Bonds CHEPLAPHARM
PRESS RELEASE published on 06/26/2025 at 10:31, 1 year ago High Demand and Attractive Pricing: CHEPLAPHARM's New 7.125% Bond Multiple Times Oversubscribed CHEPLAPHARM successfully places €750m senior secured notes at 7.125% interest rate, enhancing financial flexibility and extending maturity profile, oversubscribed transaction Senior Secured Notes Oversubscribed Financial Flexibility CHEPLAPHARM 7.125%
BRIEF published on 06/02/2025 at 10:34, 1 year 1 month ago Sandra Schröder Joins CHEPLAPHARM as VP Scientific Pharmaceutical Regulatory Affairs Quality Management CHEPLAPHARM Sandra Schröder
PRESS RELEASE published on 06/02/2025 at 10:29, 1 year 1 month ago Sandra Schröder joins CHEPLAPHARM’S Management Team as VP Scientific Sandra Schröder appointed as VP Scientific at CHEPLAPHARM, responsible for scientific areas globally. Brings 25 years of experience from F. Hoffmann-La Roche AG Pharmaceutical Industry Management CHEPLAPHARM Sandra Schröder VP Scientific
BRIEF published on 01/02/2025 at 09:19, 1 year 6 months ago CHEPLAPHARM Appoints Tamás Szóga as VP Commercial Management Expansion CHEPLAPHARM Tamás Szóga VP Commercial Pharmaceutical Strategy
PRESS RELEASE published on 01/02/2025 at 09:14, 1 year 6 months ago CHEPLAPHARM expands Management with Tamás Szóga as VP Commercial CHEPLAPHARM expands management team by appointing Tamás Szóga as VP Commercial, responsible for strategic planning and development of Global Sales division Global Sales Strategic Planning CHEPLAPHARM Tamás Szóga VP Commercial
BRIEF published on 12/16/2024 at 08:53, 1 year 7 months ago CHEPLAPHARM Acquires Gemzar from Lilly Acquisition Oncology Eli Lilly CHEPLAPHARM Gemzar
PRESS RELEASE published on 12/16/2024 at 08:48, 1 year 7 months ago CHEPLAPHARM acquires Gemzar from Lilly CHEPLAPHARM acquires Gemzar from Lilly, expanding its oncology portfolio with a proven chemotherapeutic agent for various types of cancer Acquisition Oncology CHEPLAPHARM Chemotherapy Gemzar
BRIEF published on 11/08/2024 at 10:50, 1 year 8 months ago Sebastian Braun Honored as EY Entrepreneur of the Year Entrepreneurship Family Business CHEPLAPHARM EY Award Sebastian Braun
PRESS RELEASE published on 11/08/2024 at 10:45, 1 year 8 months ago SEBASTIAN BRAUN WINS EY ENTREPRENEUR OF THE YEAR Sebastian Braun, Chairman of CHEPLAPHARM Group, wins EY Entrepreneur of the Year in 'family business' category. Recognized for outstanding leadership and business growth Entrepreneurship Business Award EY Entrepreneur Of The Year Sebastian Braun CHEPLAPHARM Group
Published on 07/17/2026 at 15:00, 1 day 2 hours ago Four Nines Gold to Showcase Hayden Hill Opportunity to U.S. Investors at OTC Markets Virtual Investor Conference
Published on 07/17/2026 at 14:00, 1 day 3 hours ago Redwood AI Announces Pricing of $3.5 Million Private Placement
Published on 07/17/2026 at 13:00, 1 day 4 hours ago Blue Lagoon Surpasses $10 Million In Revenue As Dome Mountain Production Rises To 125 Tonnes Per Day
Published on 07/17/2026 at 01:00, 1 day 16 hours ago RJK Explorations Ltd. Announces Closing of Private Placement for Gross Proceeds of $310,000
Published on 07/17/2026 at 00:00, 1 day 17 hours ago LIR Life Sciences Signs Development Services Agreement with Oxygen Handel GmbH (OH) to Advance Regulatory and Preclinical Roadmap for Transdermal Obesity Pipeline
Published on 07/18/2026 at 08:00, 9 hours 39 minutes ago Northern Data AG – Changes to the Supervisory Board and the Management Board
Published on 07/17/2026 at 20:35, 21 hours 4 minutes ago Farizon Opens Global Spare Part Distribution Center to Strengthen International Aftersales Support
Published on 07/17/2026 at 18:55, 22 hours 44 minutes ago CGTN: China vows to make AI a driver for shared prosperity amid widening AI divide
Published on 07/17/2026 at 18:32, 23 hours 7 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 07/17/2026 at 18:31, 23 hours 8 minutes ago Disclosure of transactions in own shares from July 13 to July 17, 2026
Published on 07/17/2026 at 18:00, 23 hours 39 minutes ago Information regarding compliance with gender balance rules within the Board of Directors
Published on 07/17/2026 at 17:45, 23 hours 54 minutes ago Imerys-07-2026-information-share-capital-and-voting-rights-as-of-30-June-2026
Published on 07/16/2026 at 18:08, 1 day 23 hours ago Aéroports de Paris S.A - June and half-year 2026 traffic figures
